Home  >  Products  >  RRBP1 (ribosome binding protein 1 homolog 180kDa (dog)) Blocking Peptide (the N terminal of protein) (100ug)
RRBP1 (ribosome binding protein 1 homolog 180kDa (dog)) Blocking Peptide (the N terminal of protein) (100ug)

RRBP1 (ribosome binding protein 1 homolog 180kDa (dog)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RRBP1 antibody (Catalogue #: ARP44952_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP44952
Size: 100 ug
Weight: 109kDa
Gene: 6238
Format: Lyophilized powder
Target: Analysis of cDNA clones indicates that ribosome binding protein 1 may exist in different forms due to removal of tandem repeats, or partial intraexonic splicing of RRBP1. The form presented here is lacking the canine p180 ribosome-binding domain, NQGKKAEGAQ, which is tandemly repeated close to the N-terminus in other forms that haven't been fully characterized. RRBP1 has been excluded as a candidate gene in the cause of Alagille syndrome.Analysis of cDNA clones indicates that ribosome binding protein 1 may exist in different forms due to removal of tandem repeats, or partial intraexonic splicing of RRBP1. The form presented here is lacking the canine p180 ribosome-binding domain, NQGKKAEGAQ, which is tandemly repeated close to the N-terminus in other forms that haven't been fully characterized. RRBP1 has been excluded as a candidate gene in the cause of Alagille syndrome. Alternate splicing results in multiple transcript variants.
Alternative names: DKFZp586A1420; ES/130; ES130; FLJ36146; MGC157720; MGC157721; hES
See Full Product Listings >